Lakefront Biotherapeutics | GLPG - Umsatzkosten





Umsatzkosten Veränderung Datum
argenx SE USD 121M 28.69M 2026-03
AstraZeneca USD -204M 3.48B 2026-03
Biogen USD 797.5M 302M 2026-03
Genmab DKK 81M 23M 2025-12
Gilead Sciences USD 1.44B 174M 2026-03
GlaxoSmithKline GBP 1.88B 736M 2026-03
GRIFOLS EUR 1.08B 214.82M 2026-03
Hikma Pharmaceutical USD 959M 492.5M 2025-12
Incyte USD 104.5M 16.68M 2026-03
Merck EUR 2.07B 219M 2026-03
Neurocrine Biosciences USD 13.8M 3.8M 2026-03
Novartis USD 3.46B 83M 2026-03
Roche Holding CHF 8.48B 4.61B 2025-12
Sanofi EUR 3.67B 621M 2026-03
UCB EUR 1.07B 146M 2025-12
Vertex Pharmaceuticals USD 392.8M 73.2M 2026-03